Aug 22, 2024

Appendix 4G and Corporate Governance Statement (ASX Announcement)

Melbourne, Australia; 22 August 2024: Starpharma (ASX: SPL, OTCQX: SPHRY), an innovative biotechnology company with two decades of experience in advancing dendrimer technology from the lab to the patient, today releases its Appendix 4G, Key Disclosures to Corporate Governance Principles and Recommendations, and Corporate Governance Statement, in accordance with ASX Listing Rules 4.7.3 and 4.10.3.

View/download the ASX Announcement: Appendix 4G and Corporate Governance Statement.

 This contains certain forward-looking statements.